Examination of Hydroxychloroquine Use and Hemolytic Anemia in G6PDH ‐Deficient Patients

ConclusionThis is the largest study to date evaluating G6PDH deficiency with concurrent use of HCQ. Of 11 patients with G6PDH deficiency, 2 had episodes of hemolysis, but these did not occur during HCQ therapy. These data do not support routine measurement of G6PDH levels or withholding HCQ therapy among African American patients with G6PDH deficiency.

Source: Arthritis Care and Research - February 9, 2018 Category: Rheumatology Authors: Samya Mohammad, Megan E. B. Clowse, Amanda M. Eudy, Lisa G. Criscione ‐Schreiber Tags: Brief Report Source Type: research